Congestive Heart FailureNCT01373775
Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department Siriraj Hospital
An observational study of Congestive Heart Failure and Renal Insufficiency, run by Mahidol University at 1 site in Thailand.
Trial summary
To identify the risk factors of the revisit of the adult HF patients in emergency department. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Congestive Heart Failure, Renal Insufficiency
- What is being tested?
- Patient charts reviewing
- How many people
- 533 participants
- Where
- 1 siteThailand
- Study dates
- Apr 2009to Feb 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Medical records of 533 patients,who visited the emergency department with the diagnosis of HF (ICD-10 I500, I501 and I509) in the period from 1st Jan 2008 to 31st Dec 2008, were reviewed.
Who may be able to join
- Patients age from 18 years old
- Patients who were diagnosed HF by the Framingham's criteria10
- Patients who were discharged home from emergency department
Who cannot join
- Patients age less than 18 years old
- Patients who not met Framingham's criteria, needed hospital admission, were referred to other hospital, and death
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department in Siriraj Hospital: The One Year Period.
To identify the risk factors of the revisit of the adult HF patients in emergency department.
Read the detailed description
Because heart failure (HF) is the leading cause of hospitalization and readmission in many hospitals worldwide.
Identifying the risk factors of these HF patients in emergency department is the important reason for the proper management of the HF patients in the future. And can reduce number of hospitalization and readmission in our hospital.
- Conditions
- Congestive Heart Failure, Renal Insufficiency
- Being tested
- Patient charts reviewing
- Keywords
- Heart failure, Revisit, Emergency room
- Medical subject headings
- Heart Failure, Renal Insufficiency, Emergencies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patient charts reviewingOther
Reviewing chart and identifying risk factors
| Study group | Role | What they receive |
|---|---|---|
| Revisit | HF patients who revisit the emergency department before the next appointment date. Receives: Other: Patient charts reviewing | |
| Non-revisit | HF patients who follow up on the appointment date. Receives: Other: Patient charts reviewing |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of HF patients who were revisited emergency department before the appointment date.
All HF-peatient charts were reviewed and divided in revisit group and non revisit group.
Measured: 1 year
Secondary outcomes (1)
Characteristics of the patients in revisit group
The Characteristics of the patients in both groups such as underlying diseases, ejection fraction, and time for treating in emergency department. The results were compared to find the relation between both groups.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jun 2011 (estimated)
- Study startApr 2009
- Primary completionSep 2009
- Study completionFeb 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Congestive Heart FailureStudies of the same condition, open and under way.
- More trials run by Mahidol UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 533 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mahidol University
- Sponsor type
- University, hospital or other
- Investigators
- Phuriphong Songarj, MD, Principal investigator, Department of Anesthesiology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01373775
- Sponsor's protocol ID
- 740/2551(EC1)
- Status last verified
- Jun 2011
- First submitted
- 9 Jun 2011
- Last updated
- 15 Jun 2011
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Jun 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department in Siriraj Hospital: The One Year Period.
- ClinicalTrials.gov ID
- NCT01373775
- Acronym / sponsor ID
- 740/2551(EC1)
- Conditions
- Congestive Heart Failure, Renal Insufficiency
- Keywords
- Heart failure, Revisit, Emergency room
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 533 participants (actual)
- Lead sponsor
- Mahidol UniversityUniversity, hospital or other
- Study start
- Apr 2009
- Primary completion
- Sep 2009 (actual)
- Study completion
- Feb 2010 (actual)
- First posted
- 15 Jun 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To identify the risk factors of the revisit of the adult HF patients in emergency department.
Detailed description
Because heart failure (HF) is the leading cause of hospitalization and readmission in many hospitals worldwide.
Identifying the risk factors of these HF patients in emergency department is the important reason for the proper management of the HF patients in the future. And can reduce number of hospitalization and readmission in our hospital.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Revisit | – | Other: Patient charts reviewingHF patients who revisit the emergency department before the next appointment date. |
| Non-revisit | – | Other: Patient charts reviewingHF patients who follow up on the appointment date. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Medical records of 533 patients,who visited the emergency department with the diagnosis of HF (ICD-10 I500, I501 and I509) in the period from 1st Jan 2008 to 31st Dec 2008, were reviewed.
Key inclusion criteria (3 listed)
- Patients age from 18 years old
- Patients who were diagnosed HF by the Framingham's criteria10
- Patients who were discharged home from emergency department
Key exclusion criteria (2 listed)
- Patients age less than 18 years old
- Patients who not met Framingham's criteria, needed hospital admission, were referred to other hospital, and death
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patient charts reviewingReviewing chart and identifying risk factors | Other | Non-revisit, Revisit |
Primary outcome
Number of HF patients who were revisited emergency department before the appointment date.
Time frame: 1 year
All HF-peatient charts were reviewed and divided in revisit group and non revisit group.
1 secondary outcome
Characteristics of the patients in revisit group
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jun 2011.
Related trials for Congestive Heart Failure
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Recruiting
Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor)
Heart Failure
Active, not recruiting
Assessment of Combined CCM and ICD Device in HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
Not yet recruiting
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Phuriphong Songarj, MD principal investigator
Department of Anesthesiology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Congestive Heart Failure and Renal Insufficiency, run by Mahidol University at 1 site in Thailand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Jun 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of HF patients who were revisited emergency department before the appointment date. (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2011.